{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:51:11Z","timestamp":1791618671197,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Guangdong Provincial Hospital of Chinese Medicine","award":["(2013)233"],"award-info":[{"award-number":["(2013)233"]}]},{"name":"Inheritance studio of national famous expert Xiaoyun Wang of traditional Chinese medicine, Human education of traditional Chinese medicine","award":["(2016)42"],"award-info":[{"award-number":["(2016)42"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.cyto.2019.154876","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T17:39:48Z","timestamp":1571247588000},"page":"154876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Serum biomarker analysis in patients with premature ovarian insufficiency"],"prefix":"10.1016","volume":"126","author":[{"given":"Jian","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunchun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3052-8979","authenticated-orcid":false,"given":"Xiaoyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2019.154876_b0005","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/humrep\/dev021","article-title":"The prevalence and phenotypic characteristics of spontaneous premature ovarian failure: a general population registry based study","volume":"30","author":"Haller-Kikkatalo","year":"2015","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.cyto.2019.154876_b0010","first-page":"720","article-title":"Meeting the needs of young women with secondary amenorrhea and spontaneous premature ovarian failure","volume":"99","author":"Alzubaidi","year":"2002","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.cyto.2019.154876_b0015","first-page":"47","article-title":"A case report of spontaneous pregnancy during hormonal replacement therapy for premature ovarian failure","volume":"9","author":"Akbari Asbagh","year":"2011","journal-title":"Iran. J. Reproduct. Med."},{"key":"10.1016\/j.cyto.2019.154876_b0020","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/humupd\/dmi012","article-title":"Premature ovarian failure","volume":"11","author":"Goswami","year":"2005","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.cyto.2019.154876_b0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1755-8166-6-62","article-title":"Molecular cytogenetic analysis of Xq critical regions in premature ovarian failure","volume":"6","author":"Beke","year":"2013","journal-title":"Mol. Cytogenet."},{"key":"10.1016\/j.cyto.2019.154876_b0030","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/humrep\/deh635","article-title":"Association of FMR1 repeat size with ovarian dysfunction","volume":"20","author":"Sullivan","year":"2005","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.cyto.2019.154876_b0035","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2006.09.004","article-title":"The FMR1 premutation and reproduction","volume":"87","author":"Wittenberger","year":"2007","journal-title":"Fertil Steril."},{"key":"10.1016\/j.cyto.2019.154876_b0040","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1677\/JME-10-0070","article-title":"Genes involved in human premature ovarian failure","volume":"45","author":"Persani","year":"2010","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.cyto.2019.154876_b0045","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1399-0004.2009.01359.x","article-title":"Cytogenetic analyses of premature ovarian failure using karyotyping and interphase fluorescence in situ hybridization (FISH) in a group of 1000 patients","volume":"78","author":"Lakhal","year":"2010","journal-title":"Clin. Genet."},{"key":"10.1016\/j.cyto.2019.154876_b0050","first-page":"210","article-title":"Autoimmune premature ovarian failure","volume":"15","author":"Komorowska","year":"2016","journal-title":"Prz Menopauzalny."},{"key":"10.1016\/j.cyto.2019.154876_b0055","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1034\/j.1600-0897.2001.d01-5.x","article-title":"Immune disorders in women with premature ovarian failure in initial period","volume":"46","author":"Chernyshov","year":"2001","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.cyto.2019.154876_b0060","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.autrev.2010.06.008","article-title":"An immunological insight into premature ovarian failure (POF)","volume":"9","author":"Dragojevi\u0107-Diki\u0107","year":"2010","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.cyto.2019.154876_b0065","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1034\/j.1398-9995.1999.00251.x","article-title":"Regulation of ICAM-3 and other adhesion molecule expressions on eosinophils in vitro. Effects of dexamethasone","volume":"54","author":"Juan","year":"1999","journal-title":"Allergy"},{"key":"10.1016\/j.cyto.2019.154876_b0070","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.cellsig.2010.11.022","article-title":"Signaling of interleukin-17 family cytokines in immunity and inflammation","volume":"23","author":"Chang","year":"2011","journal-title":"Cell Signal"},{"key":"10.1016\/j.cyto.2019.154876_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122807","article-title":"Signa ling through IL-17C\/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis","volume":"10","author":"Conti","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2019.154876_b0080","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13287-018-0772-x","article-title":"hPMSC transplantation restoring ovarian function in premature ovarian failure mice is associated with change of Th17\/Tc17 and Th17\/Treg cell ratios through the PI3K\/Akt signal pathway","volume":"9","author":"Yin","year":"2018","journal-title":"Stem Cell Res Ther."},{"key":"10.1016\/j.cyto.2019.154876_b0085","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00441-013-1567-0","article-title":"High density of IL-17-producing cells is associated with improved prognosis for advanced epithelial ovarian cancer","volume":"352","author":"Lan","year":"2013","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.cyto.2019.154876_b0090","doi-asserted-by":"crossref","unstructured":"D. Gozalbo, V. Maneu, M.L. Gil, Role of IFN-gamma in immune responses to Candida albicans infections, Front. Biosci. (Landmark Ed). 19 (2014) 1279\u20131290. PMID: .","DOI":"10.2741\/4281"},{"key":"10.1016\/j.cyto.2019.154876_b0095","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1158\/1078-0432.CCR-06-2833","article-title":"Loss of IFN gamma receptor is an independent prognostic factor in ovarian cancer","volume":"13","author":"Duncan","year":"2007","journal-title":"Clin. Can. Res."},{"key":"10.1016\/j.cyto.2019.154876_b0100","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/1074-7613(94)90087-6","article-title":"Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN \u03b3 receptors","volume":"1","author":"Dighe","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2019.154876_b0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1189\/jlb.1208761","article-title":"Interferon-\u03bbs: the modulators of antivirus, antitumor, and immune responses","volume":"86","author":"Li","year":"2009","journal-title":"J. Leukocyte Biol."},{"key":"10.1016\/j.cyto.2019.154876_b0110","first-page":"9552","article-title":"Association of IL-29 with the lipid metabolic features of polycystic ovary syndrome","volume":"11","author":"Liu","year":"2018","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.cyto.2019.154876_b0115","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1006\/exnr.1999.7127","article-title":"Expression of neurturin, GDNF, and GDNF family-receptor mRNA in the developing and mature mouse","volume":"158","author":"Golden","year":"1999","journal-title":"Exp Neurol."},{"key":"10.1016\/j.cyto.2019.154876_b0120","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1096\/fj.15-280313","article-title":"WNT5a is required for normal ovarian follicle development and antagonizes gonadotropin responsiveness in granulosa cells by suppressing canonical WNT signaling","volume":"30","author":"Abedini","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.cyto.2019.154876_b0125","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fonc.2018.00124","article-title":"Beyond the biomarker: understanding the diverse roles of human epididymis protein 4 in the pathogenesis of epithelial ovarian cancer","volume":"8","author":"James","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cyto.2019.154876_b0130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1095\/biolreprod.112.102327","article-title":"Curry TE, activation of the PKC pathway stimulates ovarian cancer cell proliferation, migration, and expression of MMP7 and MMP10","volume":"89","author":"Al-Alem","year":"2013","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.cyto.2019.154876_b0135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1477-7827-10-51","article-title":"Developmental expression and function of DKKL1\/Dkkl1 in humans and mice","volume":"10","author":"Yan","year":"2012","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.cyto.2019.154876_b0140","doi-asserted-by":"crossref","unstructured":"D. Jackson, R.A. Craven, R.C. Huston, I. Graze, P. Lueth, R.P. Tonge, J.L. Hartley, J.A. Nickson, S.J. Rayner, C. Johnston, B. Dieplinger, Hubalek M, N. Wilkinson, T.J. Perren, S. Kehoe, G.D. Hall, G. Daxenbichler, H. Dieplinger, P.J. Selby, R.E. Banks, Proteomic profiling identifies Afamin as a potential biomarker for ovarian cancer, Clin. Can. Res. 13 (2007) 7370\u20137379. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-0747.","DOI":"10.1158\/1078-0432.CCR-07-0747"},{"key":"10.1016\/j.cyto.2019.154876_b0145","doi-asserted-by":"crossref","unstructured":"A. Koninger, P. Edimiris, L. Koch, A. Enekwe, C. Lamina, S. Kasimir-Bauer, R. Kimmig, H. Dieplinger, Serum concentrations of afamin are elevated in patients with polycystic ovary syndrome, Endocr Connect. 3 (2014) 120\u2013126. Serum concentrations of afamin are elevated in patients with polycystic ovary syndrome.","DOI":"10.1530\/EC-14-0053"},{"key":"10.1016\/j.cyto.2019.154876_b0150","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00404-018-4897-z","article-title":"Afamin: an early predictor of preeclampsia","volume":"298","author":"K\u00f6ninger","year":"2018","journal-title":"Arch. Gynecol. Obstet."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466619303059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466619303059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:54:23Z","timestamp":1760907263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466619303059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":30,"alternative-id":["S1043466619303059"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2019.154876","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum biomarker analysis in patients with premature ovarian insufficiency","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2019.154876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154876"}}